SEOUL, Feb. 9 (Korea Bizwire) –The Korea Exchange announced on February 8 that it will list Samsung Asset Management’s KODEX Global Obesity Treatment TOP2 Plus Exchange Traded Fund (ETF) on the stock market on February 14. This fund marks the first obesity treatment-themed product in South Korea, investing in 10 global companies related to obesity [...]
SEOUL, Jan. 31 (Korea Bizwire) –Samsung Biologics has disclosed that the total compensation package for its employees, including wages and benefits, can reach up to 100 million KRW annually for first-year employees. On January 31, it was revealed that Samsung Biologics had shared a “Total Compensation Statement” with its employees for the first time, detailing [...]
SEOUL, Jan. 16 (Korea Bizwire) — The Korea Research Institute of Chemical Technology (KRICT) announced on January 15 that a team led by Dr. Lee Seong-gyun and Dr. Kim Hong-ki has developed new biomimetic organ-on-a-chip technology. This platform is expected to be highly effective in analyzing chronic inflammation in patients and evaluating the efficacy of therapeutics. Organ-on-a-chip [...]
SEOUL, Jan. 15 (Korea Bizwire) — As South Korea grapples with an aging population, pharmaceutical companies are increasingly looking at ‘medifood’ as a potential new growth area. Medifood, also known as ‘food for special medical purposes,’ includes beverages and meals specially designed for the elderly or others who require particular nutritional care due to health reasons. On [...]
SEOUL, Jan. 10 (Korea Bizwire) – The South Korean Ministry of Food and Drug Safety (MFDS) has announced that clinical trials for low-risk medical devices, including medical artificial intelligence (AI), can now be conducted without the need for clinical plan approval from the MFDS. This change will also allow trials to be conducted outside of designated [...]
SEOUL, Dec. 20 (Korea Bizwire) – The utilization of virtual healthcare is experiencing a notable surge, marked by a substantial increase in accessibility and extended service hours. A key factor contributing to this surge is the comprehensive approval of non-face-to-face medical consultations during nighttime and holidays, playing a pivotal role in the growing user base. Notably, [...]
SEOUL, Dec. 18 (Korea Bizwire) – As South Korea grapples with an aging population, the importance of bone health has come to the forefront, prompting local pharmaceutical and biotech companies to intensify their efforts to develop and market generic osteoporosis treatments. According to industry sources on December 17, the patent for Prolia, an osteoporosis medication developed [...]
SEOUL, Dec. 12 (Korea Bizwire) — SK bioscience Co. said Tuesday it has started supplying Novavax’s updated COVID-19 vaccine to target the XBB.1.5 subvariant in South Korea. The vaccine, the only non-messenger RNA formulation against COVID-19 in the world, will be available for free at designated hospitals and health centers across the country starting next [...]
SEOUL, Nov. 30 (Korea Bizwire) — Celltrion Healthcare Co. said Thursday its new autoimmune disease treatment, Zymfentra, will make its U.S. market debut on Feb. 29 next year. Zymfentra, a subcutaneous injection formulation of Celltrion’s infliximab Remsima, won approval from the U.S. Food and Drug Administration last month. The sales affiliate of South Korean pharmaceutical [...]
SEOUL, Oct. 30 (Korea Bizwire) – The pharmaceutical and biotechnology industry is making significant strides in enhancing its presence in the beauty sector, particularly in the realm of cosmetics. Industry experts suggest that this strategic shift is aimed at attracting consumers and driving sales by emphasizing pharmaceutical companies’ focus on health. In recent developments, the Yuhan [...]